Zurueck zur Suche

Reporte zur Charge U8192BA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IN 2 CA 2 HI 1 AL 1 GA 1 TX 1 CO 1

VAERS 2711506

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge u8192ba

schwer
Staat
CA
Alter
35,0
Geschlecht
F
Eingang
08.11.2023
Impfdatum
07.11.2023
Beginn
07.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Deafness Malaise Syncope

Symptomtext

Provider gave this patient two vaccines, Fluzone Quad and Spikevax. After getting the vaccines the patient reported feeling not well. Provider came to get me to tell me he patient wasn't feeling well. I spoke to the patient and tried to calm her by taking deep breaths while sitting in the vaccine chair. She said she couldn't hear me, I put both hands on her shoulder to keep her in the chair. She fainted in the chair and provider and I carefully moved her to the floor. As we were moving her to the floor she woke and quickly oriented herself. I had her still lay down ground and raised her legs.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2710609

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192BA

schwer
Staat
CA
Alter
12,0
Geschlecht
F
Eingang
06.11.2023
Impfdatum
06.11.2023
Beginn
06.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Disorientation Hypotonia Loss of consciousness Pallor Unresponsive to stimuli

Symptomtext

Patient loss conscientiousness after administration of second vaccine. Patient went limp in chair and was non response for 2 minutes. Then patient woke up and was pale and disoriented. After several minutes patient could respond to questions and was breathing normally. Color returned to patients face.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Blood pressure 98/94 11/6/23
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
concerta
Allergien
none
Vorherige Impfungen
-

VAERS 2725253

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192BA

moderat
Staat
HI
Alter
59,0
Geschlecht
M
Eingang
18.12.2023
Impfdatum
13.12.2023
Beginn
15.12.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Pain Pain in extremity

Symptomtext

Pt reports that two days after flu shot, he started developing radiating L arm pain. The pain has been increasing every day, and range of motion has become more limited every day. At this time, can abduct arm about 30 degrees. Reports 8-9/10 radiating pain while on ibuprofen and prednisone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
Advised to follow up at All Access ortho for imaging.
Aktuelle Erkrankungen
Denies
Vorgeschichte
Denies
Andere Medikamente
None
Allergien
Denies
Vorherige Impfungen
-

VAERS 2722801

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192BA

mild
Staat
AL
Alter
49,0
Geschlecht
F
Eingang
11.12.2023
Impfdatum
07.12.2023
Beginn
07.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Immediate post-injection reaction Shoulder injury related to vaccine administration

Symptomtext

The patient instantly felt pain in the shoulder. The patient continued to have shoulder pain and saw an orthopedic doctor who diagnosed SIRVA.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2720102

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192BA

gering
Staat
GA
Alter
10,0
Geschlecht
F
Eingang
01.12.2023
Impfdatum
01.12.2023
Beginn
01.12.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered No adverse event

Symptomtext

PATIENTS GOT 2 FLU VACCINE BUT NO SYMPTOMS OR ANY OUTCOME

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2715088

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192BA

gering
Staat
TX
Alter
0,2
Geschlecht
F
Eingang
17.11.2023
Impfdatum
15.11.2023
Beginn
15.11.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age Somnolence

Symptomtext

Fluzone PF quadrivalent dose was given in error to 2 month old infant on 11/15/23. When error caught, medical assistant notified physician immediately. Parent was notified. Follow up call with family on 11/16/23. During follow up call mom stated infant had temperature of 100 degrees and was a little sleepy No worrisome side effects and temperature was down later in the day. Mom is monitoring and will call clinic with concerns.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
no known
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2712159

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192BA

gering
Staat
CO
Alter
4,0
Geschlecht
F
Eingang
09.11.2023
Impfdatum
07.11.2023
Beginn
07.11.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Patient had received flu immunization on 10/7/23. Patient came to clinic for flu immunization on 11/7/23. Patient received flu immunization in error. Provider was notified. Patient's parent was also notified of error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2703551

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192BA

gering
Staat
IN
Alter
0,9
Geschlecht
F
Eingang
27.10.2023
Impfdatum
16.10.2023
Beginn
16.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product storage error

Symptomtext

Fluzone QIV was exposed to low temperature excursion earlier today (low of negative 4.6C for 45 minutes) due to the repairman converting the refrigerator to a freezer and was administered post excursion with no adverse event; Fluzone QIV was exposed to low temperature excursion earlier today (low of negative 4.6C for 45 minutes) due to the repairman converting the refrigerator to a freezer and was administered post excursion with no adverse event; Initial information received on 16-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2023SA318835(CLUSTER), 2023SA321113(CLUSTER), 2023SA319649(CLUSTER), 2023SA321127(CLUSTER) and 2023SA319055(CLUSTER). This case involves a 11 months old female patient who was administered influenza quadrival A-B vaccine [Fluzone QIV] and was exposed to low temperature excursion earlier today (low of negative 4.6c for 45 minutes) due to the repairman converting the refrigerator to a freezer and was administered post excursion with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 16-Oct-2023, the patient received a dose of 0.5 ml once of suspect influenza quadrival A-B vaccine (lot: U8192BA; expiry date: Jun-2024; strength: standard) via intramuscular route in the left thigh for Immunization. On 16-Oct-2023 the influenza quadrival A-B vaccine was exposed to low temperature excursion earlier today (low of negative 4.6c for 45 minutes) due to the repairman converting the refrigerator to a freezer and was administered post excursion with no adverse event (product storage error) (unknown latency) (poor quality product administered) (latency: same day). Action taken was not applicable. At time of reporting, the outcome was Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2699905

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192BA

gering
Staat
IN
Alter
20,0
Geschlecht
F
Eingang
23.10.2023
Impfdatum
16.10.2023
Beginn
16.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Poor quality product administered Product storage error

Symptomtext

fluzone qiv np was exposed to low temperature excursion earlier today (low of negative 4.6c for 45 minutes) due to the repairman converting the refrigerator to a freezer and administered post excursion with no reported adverse event; fluzone qiv np was exposed to low temperature excursion earlier today (low of negative 4.6c for 45 minutes) due to the repairman converting the refrigerator to a freezer and administered post excursion with no reported adverse event; Initial information received on 16-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2023SA318835(CLUSTER), 2023SA318839(CLUSTER), 2023SA319649(CLUSTER), 2023SA321113(CLUSTER) and 2023SA321127(CLUSTER). This case involves a 20 years old female patient who was administered influenza quadrival A-B vaccine [Fluzone QIV] which was exposed to low temperature excursion earlier today (low of negative 4.6C for 45 minutes) due to the repairman converting the refrigerator to a freezer and administered post excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 16-Oct-2023, the patient received a dose of 0.5 ml once of suspect influenza quadrival A-B vaccine (Suspension for injection) (lot: U8192BA; expiry date: Jun-2024; strength: standard) via intramuscular route in the right deltoid for Immunization. On 16-Oct-2023 influenza quadrival A-B vaccine was exposed to low temperature excursion earlier today (low of negative 4.6c for 45 minutes) due to the repairman converting the refrigerator to a freezer and administered post excursion with no reported adverse event (product storage error) (unknown latency) (poor quality product administered) (latency: same day). Action taken was not applicable. At time of reporting, the outcome was Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-